A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma (Q71518845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

Y Ichiya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Y Kuwabara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

M Sasaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

T Yoshida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J Omagari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Y Akashi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

A Kawashima

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

T Fukumura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

K Masuda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

Annals of Nuclear Medicine

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

193-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03165392

19 October 2019

exact match

0 references

cites work

Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy

1 reference

12 December 2020

Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study

1 reference

12 December 2020

Recurrence of colorectal tumors: PET evaluation

1 reference

12 December 2020

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

12 December 2020

Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.

1 reference

12 December 2020

Differential diagnosis of lung tumor with positron emission tomography: a prospective study

1 reference

12 December 2020

[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer

1 reference

12 December 2020

Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity

1 reference

12 December 2020

Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy

1 reference

12 December 2020

Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

1 reference

12 December 2020

Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment

1 reference

12 December 2020

Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose

1 reference

12 December 2020

Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities

1 reference

12 December 2020

Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors

1 reference

12 December 2020

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

1 reference

12 December 2020

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

12 December 2020

Monitoring liver tumor therapy with [18F]FDG positron emission tomography

1 reference

12 December 2020

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography

1 reference

12 December 2020

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

12 December 2020

Glucose utilization in vivo by human pulmonary neoplasms

1 reference

12 December 2020

The applications of PET in clinical oncology

1 reference

12 December 2020

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

12 December 2020

PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy

1 reference

12 December 2020

Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer

1 reference

12 December 2020

Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy

1 reference

12 December 2020

Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose.

1 reference

12 December 2020

Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography

1 reference

12 December 2020

High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study

1 reference

12 December 2020

The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis

1 reference

12 December 2020

Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry

1 reference

12 December 2020

Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy

1 reference

12 December 2020

In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Positron emission tomography in patients with glioma. A predictor of prognosis.

1 reference

12 December 2020

Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03165392

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8800448%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference